The health effects of cannabis and cannabinoids : the current state of evidence and recommendations for research /

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the sta...

Full description

Saved in:
Bibliographic Details
Format: eBook
Language:English
Published: Washington, DC : The National Academies Press, [2017]
Subjects:
Online Access:CONNECT
CONNECT
LEADER 07236cam a2200649 i 4500
001 mig00005367043
003 OCoLC
005 20210517053804.8
006 m o d
007 cr cn|||||||||
008 170502s2017 dcua obt 000 0 eng
016 7 |a 101705167  |2 DNLM 
019 |a 982144200  |a 982222808  |a 982329138  |a 982409781  |a 982451401  |a 988097865 
020 |a 9780309453042 
020 |a 0309453046 
020 |a 9780309453059 
020 |a 0309453054 
024 8 |a 99972651314 
035 |a (OCoLC)969344042  |z (OCoLC)982144200  |z (OCoLC)982222808  |z (OCoLC)982329138  |z (OCoLC)982409781  |z (OCoLC)982451401  |z (OCoLC)988097865 
035 0 0 |a ocm00000001wrldshrocn969344042 
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d CUS  |d UAB  |d MMU  |d EBLCP  |d YDX  |d N$T  |d IUL  |d CN4UL  |d XFF  |d OCLCO  |d NLM  |d OCLCO  |d OCLCQ  |d U3G  |d OCLCA  |d TEU  |d AGLDB  |d IGB  |d CN8ML  |d UMK  |d SNK  |d INTCL  |d MHW  |d BTN  |d AUW  |d OCLCF  |d OCLCQ  |d VTS  |d FVL  |d D6H  |d OCLCQ  |d G3B  |d S8I  |d S8J  |d S9I  |d ORU  |d STF  |d OCLCQ  |d SFB  |d OCLCO  |d UKAHL  |d OCLCO  |d OCLCA  |d OCLCQ  |d OCLCA 
042 |a pcc 
043 |a n-us--- 
049 |a TXMM 
050 4 |a QP801.C27 
060 0 0 |a 2017 E-555 
060 0 0 |a QV 766 
082 0 4 |a 615 
245 0 4 |a The health effects of cannabis and cannabinoids :  |b the current state of evidence and recommendations for research /  |c Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda, Board on Population Health and Public Health Practice, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine ; Health and Medicine Division. 
264 1 |a Washington, DC :  |b The National Academies Press,  |c [2017] 
300 |a 1 online resource (xviii, 468 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 3 |a Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agenda--outlining gaps in current knowledge and opportunities for providing additional insight into these issues--that summarizes and prioritizes pressing research needs. 
536 |a This activity was supported by Grant No. ADHS16-113368 from the Arizona Department of Health Services, Grant No. 910-16-SC from the CDC Foundation, Grant No. 200-2011-38807, Task Order #47 from the Centers for Disease Control and Prevention, Grant No. HHSN263201200074I, Task Order #91 from the National Institutes of Health, and Grant No. 151027 from Oregon Health Authority. Additional support was received by Alaska Mental Health Trust Authority; California Department of Public Health; The Colorado Health Foundation; Mat-Su Health Foundation; National Highway Traffic Safety Administration; National Institutes of Health/National Cancer Institute; National Institutes of Health/National Institute on Drug Abuse; the Robert W. Woodruff Foundation; Truth Initiative; U.S. Food and Drug Administration; and Washington State Department of Health. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. 
588 0 |a Online resource; title from PDF title page (viewed May 26, 2017). 
505 0 |a Summary -- Introduction -- Cannabis -- Cannabis: prevalence of use, regulation, and current policy landscape -- Therapeutic effects of cannabis and cannabinoids -- Cancer -- Cardiometabolic risk -- Respiration disease -- Immunity -- Injury and death -- Prenatal, perinatal, and neonatal exposure to cannabis -- Psychosocial -- Mental health -- Problem cannabis use -- Cannabis use and the abuse of other substances -- Challenges and barriers in conducting cannabis research -- Recommendations to support and improve cannabis research agenda -- Appendix A: Glossary -- Appendix B: Study approach -- Appendix C: Systematic reviews -- Appendix D: Public session agendas -- Appendix E: Biographical sketches for Committee members, staff, fellow, and advisor. 
590 |a EBSCO eBook Academic Comprehensive Collection North America 
650 0 |a Marijuana  |x Health aspects  |z United States. 
650 0 |a Marijuana  |x Government policy  |z United States. 
650 0 |a Marijuana  |x Risk factors  |z United States. 
650 0 |a Marijuana abuse  |z United States. 
650 0 |a Cannabis  |x Therapeutic use  |z United States  |x Testing. 
650 0 |a Cannabis  |x Therapeutic use  |x Effectiveness  |z United States. 
650 0 |a Cannabinoids  |x Research  |z United States. 
710 2 |a National Academies of Sciences, Engineering, and Medicine (U.S.).  |b Committee on the Health Effects of Marijuana,  |e issuing body. 
730 0 |a WORLDSHARE SUB RECORDS 
776 0 8 |i Print version:  |a Division, Health and Medicine.  |t Health Effects of Cannabis and Cannabinoids : The Current State of Evidence and Recommendations for Research.  |d Washington, D.C. : National Academies Press, ©1969  |z 9780309453042 
856 4 0 |u https://ezproxy.mtsu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1500030  |z CONNECT  |3 EBSCO  |t 0 
907 |a 4639454  |b 05-27-21  |c 06-30-20 
998 |a wi  |b 05-27-21  |c m  |d z   |e -  |f eng  |g dcu  |h 4  |i 2 
994 |a 92  |b TXM 
999 f f |i c1936e3e-c261-47d7-9e11-f547142a6e72  |s ae56cf0d-b5a7-418a-bdd7-f579cd7e600e  |t 0 
952 f f |t 1  |e QP801.C27  |h Library of Congress classification 
856 4 0 |3 EBSCO  |t 0  |u https://ezproxy.mtsu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1500030  |z CONNECT